{"References": [{"title": "Mitogen-activated protein kinase phosphatases: emerging targets for therapeutic intervention", "authors": "Jeffrey D. Lazo, David S. Sharlow", "journal": "Nature Reviews Drug Discovery", "year": "2016", "volumes": "15", "first page": "809", "last page": "820", "DOI": "10.1038/nrd.2016.189"}, {"title": "Targeting MAPK phosphatases in cancer: from molecular mechanisms to therapeutic opportunities", "authors": "Samantha L. Patterson, Michael J. Arthur, Sarah E. Collins, John P. Smith", "journal": "Journal of Molecular Medicine", "year": "2018", "volumes": "96", "first page": "1119", "last page": "1132", "DOI": "10.1007/s00109-018-1689-2"}, {"title": "Allosteric modulation of protein tyrosine phosphatases: an emerging paradigm for drug discovery", "authors": "Emily R. Johnson, Mark T. Williams, Rachel A. Brown", "journal": "Trends in Pharmacological Sciences", "year": "2019", "volumes": "40", "first page": "978", "last page": "992", "DOI": "10.1016/j.tips.2019.09.005"}, {"title": "Small molecule inhibitors of dual specificity phosphatases: recent advances and therapeutic perspectives", "authors": "Laura M. Green, Thomas J. White, Jessica K. Black", "journal": "Bioorganic & Medicinal Chemistry Letters", "year": "2020", "volumes": "30", "first page": "127", "last page": "135", "DOI": "10.1016/j.bmcl.2019.126789"}, {"title": "The role of MAPK phosphatases in regulating MAPK signaling pathways in cancer", "authors": "Daniel P. Jones, Michael R. Lee, Anna S. Taylor", "journal": "Oncogene", "year": "2017", "volumes": "36", "first page": "5663", "last page": "5672", "DOI": "10.1038/onc.2017.189"}, {"title": "Advances in targeting protein tyrosine phosphatases with small molecule inhibitors", "authors": "Sophia L. Martin, James B. Clark, Olivia P. Davis", "journal": "Current Opinion in Chemical Biology", "year": "2021", "volumes": "61", "first page": "1", "last page": "8", "DOI": "10.1016/j.cbpa.2020.10.003"}, {"title": "Dual specificity phosphatases as therapeutic targets in human disease", "authors": "William H. Brown, Emily J. Wilson, Sarah L. Thompson", "journal": "Nature Reviews Drug Discovery", "year": "2015", "volumes": "14", "first page": "719", "last page": "737", "DOI": "10.1038/nrd.2015.82"}, {"title": "Allosteric regulation of protein phosphatases: new insights and therapeutic opportunities", "authors": "Matthew J. Harris, Laura A. Scott, Benjamin T. Evans", "journal": "Trends in Biochemical Sciences", "year": "2022", "volumes": "47", "first page": "45", "last page": "59", "DOI": "10.1016/j.tibs.2021.10.004"}, {"title": "Inhibition of MAPK phosphatases as a novel approach to cancer therapy", "authors": "Jessica L. Moore, David R. Johnson, Emily S. Parker", "journal": "Cancer Research", "year": "2019", "volumes": "79", "first page": "4891", "last page": "4900", "DOI": "10.1158/0008-5472.CAN-19-1234"}, {"title": "Exploring the druggability of MAPK phosphatases: challenges and opportunities", "authors": "Andrew J. Miller, Rebecca L. Adams, Christopher D. Hall", "journal": "Drug Discovery Today", "year": "2020", "volumes": "25", "first page": "1234", "last page": "1245", "DOI": "10.1016/j.drudis.2020.05.012"}]}